CHATSWORTH, Calif.--(BUSINESS WIRE)--North American Scientific, Inc. (Nasdaq:NASM), operating as NAS Medical, today announced it has initiated clinical experience with the next generation ClearPath-HDR device at Northpoint Cancer Center in Dallas, Texas. The ClearPath-HDR device was implanted by Dr. Peter Beitsch of the Dallas Surgical Group and treatment was successfully completed in August.
